Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Organ Modelling Discovery

RepliGut® Model Systems

Recreating the human intestinal epithelium.
Read More
Organ Modelling Discovery

Next Generation 3D Cell Technologies Assays, Services & Products

CoSeedis™ Assays
Read More
Pharma Data

Multi-Omics Data Analysis and Management

Data is one of the most important assets for a company but multi-omics data analysis is a challenging field.
Read More
Pharma Data

Interview with Vaishak Belle, Chancellor’s Fellow and Reader at the School of Informatics, University of Edinburgh 

Vaishak Belle, Chancellor’s Fellow and Reader at the University of Edinburgh, discusses his work on explainable AI and ethics.
Read More
Pharma Data

From Big Data to Smart Knowledge: Semantics Search 2.0

Read More
SmartLabs & Automation

Verulam: Chronect XPR

Read More
Target Based Discovery

How DEL Screening is Used in Living Cells

Living cells create a more relevant physiological environment for DEL screening, says Dr Iolanda Micco, Associate Director of Chemistry & Alliances at Vipergen
Read More
AI, Machine Learning & Computational Drug Design

Interview with Martin Fergie, Lecturer in Health Sciences at the University of Manchester 

Martin Fergie, Lecturer in Health Sciences at the University of Manchester, discusses the challenges and future opportunities of AI and ML for bioinformatics.
Read More
Target Based Discovery

First Paediatric Patients Enrolled in Phase III Clinical Trial for Rare Genetic Disease

A clinical trial for the drug leniolisib will go ahead in studying paediatric patients with the rare genetic disease ADPS.
Read More
Organ Modelling Discovery

Organoids: Opening New Doors for Cancer Research

Organoids are three-dimensional tissue cultures grown from stem cells. They have been among the most important and exciting developments in medical sciences in the last decade.
Read More

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Read More
AI, Machine Learning & Computational Drug Design

Interview with Thierry Dorval, Head of Data Sciences & Data Management at Servier

Thierry Dorval from Servier talks about AI methods, their limitations, and how they are changing the way that data is viewed in the pharmaceutical industry.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery